Preclinical studies indicate that GLP-1 RAs can attenuate atherosclerosis by reducing vascular inflammation, lowering oxidative stress, and inhibiting the proliferation and activation of vascular smooth muscle cells [51, 52]. The gene discussed is GLP1R; the disease is atherosclerosis.